Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal Supplements.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annual Review of Pharmacology and Toxicology

• Publication date

  2017-01-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1146/annurev-pharmtox-010716-105010PMID 27648763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements

  2015cited by this paper
• Amanita phalloides poisoning: Mechanisms of toxicity and treatment.

  2015cited by this paper
• Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells

  2015cited by this paper
• Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity

  2015cited by this paper
• A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients

  2015cited by this paper
• Exploring the nutraceutical potential of polyphenols from black, green and white tea infusions - an overview.

  2015cited by this paper
• Enzyme‐ and transporter‐mediated beverage–drug interactions: An update on fruit juices and green tea

  2015influential reference
• Interactions between Transporters and Herbal Medicines/Drugs: A Focus on Hepatoprotective Compounds.

  2015cited by this paper
• Herbal hepatotoxicity: current status, examples, and challenges

  2015cited by this paper
• Herbal products and the liver: a review of adverse effects and mechanisms.

  2015cited by this paper
• The mechanisms of action of St. John’s wort: an update

  2015cited by this paper
• A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives

  2015cited by this paper
• Hepatotoxicity of herbal and dietary supplements: an update

  2015cited by this paper
• Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects

  2015cited by this paper
• Effects of anthocyans on the expression of organic anion transporting polypeptides (SLCOs/OATPs) in primary human hepatocytes.

  2015cited by this paper
• Multiple ABC Transporters Efflux Baicalin

  2015cited by this paper
• Interaction of Drug or Food with Drug Transporters in Intestine and Liver.

  2015cited by this paper
• Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro.

  2015cited by this paper
• Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits

  2015cited by this paper
• Energy metabolism in the liver.

  2014cited by this paper
• Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug–Drug Interactions

  2014cited by this paper
• Intestinal lipid absorption and lipoprotein formation

  2014cited by this paper
• Warfarin Interactions with Medicinal Herbs

  2014cited by this paper
• Drug interactions with phytotherapeutics in oncology

  2014cited by this paper
• ATP‐binding cassette transporters in liver

  2014cited by this paper
• Effects of anthocyanidins and anthocyanins on the expression and catalytic activities of CYP2A6, CYP2B6, CYP2C9, and CYP3A4 in primary human hepatocytes and human liver microsomes.

  2014cited by this paper
• Inhibitory effect of medicinal plant-derived carboxylic acids on the human transporters hOAT1, hOAT3, hOATP1B1, and hOATP2B1.

  2014cited by this paper
• Traditional Medicines in the World: Where to Go Next?

  2014cited by this paper
• Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects

  2014cited by this paper
• Organic anion-transporting polypeptides.

  2014cited by this paper
• Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells.

  2014influential reference
• Inhibitory effect of anthocyanidins on hepatic glutathione S-transferase, UDP-glucuronosyltransferase and carbonyl reductase activities in rat and human

  2013influential reference
• Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives.

  2013influential reference
• Breast Cancer Resistance Protein-Mediated Efflux of Luteolin Glucuronides in HeLa Cells Overexpressing UDP-Glucuronosyltransferase 1A9

  2013influential reference
• Long-Lasting Inhibitory Effect of Apple and Orange Juices, but Not Grapefruit Juice, on OATP2B1-Mediated Drug Absorption

  2013cited by this paper
• Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin

  2013influential reference
• Green tea extract affects the cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats.

  2013cited by this paper
• Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.

  2013cited by this paper
• One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.

  2013cited by this paper
• The SLC2 (GLUT) family of membrane transporters.

  2013cited by this paper
• Glucose transport families SLC5 and SLC50.

  2013cited by this paper
• Herb-drug interactions: an overview of systematic reviews.

  2013cited by this paper
• Transport of the areca nut alkaloid arecaidine by the human proton‐coupled amino acid transporter 1 (hPAT1)

  2013cited by this paper
• The role of amino acid transporters in nutrition

  2013cited by this paper
• Omics and drug response.

  2013cited by this paper
• Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.

  2013influential reference
• The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs

  2013cited by this paper
• Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.

  2013cited by this paper
• Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.

  2013influential reference
• Pharmacokinetic Herb-Drug Interactions (Part 1): Origins, Mechanisms, and the Impact of Botanical Dietary Supplements

  2012cited by this paper
• Botanical-Drug Interactions: A Scientific Perspective

  2012cited by this paper
• Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning

  2012cited by this paper
• Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion–Transporting Polypeptides

  2012cited by this paper
• The emerging role of transport systems in liver function tests.

  2012cited by this paper
• Drug transport by Organic Anion Transporters (OATs).

  2012cited by this paper
• The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters.

  2012cited by this paper
• The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.

  2012cited by this paper
• Disposition pathways and pharmacokinetics of herbal medicines in humans.

  2012cited by this paper
• An update on the ability of St. John's wort to affect the metabolism of other drugs

  2012cited by this paper
• Intravenous Silibinin as ‘Rescue Treatment’ for On-Treatment Non-Responders to Pegylated Interferon/Ribavirin Combination Therapy

  2011cited by this paper
• Silybin and the liver: from basic research to clinical practice.

  2011cited by this paper
• The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.

  2011cited by this paper
• Warfarin-Cranberry Juice Interaction

  2011cited by this paper
• Herb-drug interactions involving drug metabolizing enzymes and transporters.

  2011cited by this paper
• The effect of grapefruit juice on drug disposition

  2011cited by this paper
• Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro

  2011cited by this paper
• The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans

  2011influential reference
• Pharmacogenetics of drug transporters in the enterohepatic circulation.

  2011cited by this paper
• Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein.

  2011influential reference
• Hepatic glucuronidation of resveratrol: interspecies comparison of enzyme kinetic profiles in human, mouse, rat, and dog.

  2011cited by this paper
• Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression.

  2010cited by this paper
• Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

  2010cited by this paper
• Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study

  2010cited by this paper
• Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

  2010cited by this paper
• Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.

  2010cited by this paper
• Grapefruit-Drug Interactions

  2010cited by this paper
• Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).

  2010cited by this paper
• Getting the mOST from OST: Role of Organic Solute Transporter, OSTα-OSTβ, in bile acid and steroid metabolism

  2010cited by this paper
• Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.

  2009cited by this paper
• Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo.

  2009cited by this paper
• Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides

  2009cited by this paper
• Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol

  2009cited by this paper
• Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1

  2009influential reference
• Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations

  2009cited by this paper
• Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.

  2008cited by this paper
• An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin

  2008cited by this paper
• Knollenblätterpilzvergiftung

  2008cited by this paper
• Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

  2008cited by this paper
• Herbal product use by persons enrolled in the hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial

  2007cited by this paper
• Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.

  2007influential reference
• In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta.

  2007cited by this paper
• Intestinal and hepatic glucuronidation of flavonoids.

  2007cited by this paper
• St. John's wort: Role of active compounds for its mechanism of action and efficacy

  2007cited by this paper
• Contents of Forthcoming Issues · Themenvorschau

  2007cited by this paper
• Effects of Repeated Green Tea Catechin Administration on Human Cytochrome P450 Activity

  2006cited by this paper
• Molecular characterization and inhibition of amanitin uptake into human hepatocytes.

  2006cited by this paper
• Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.

  2005influential reference
• Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells.

  2005cited by this paper
• FLAVONOIDS AS A NOVEL CLASS OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP1B1 (OATP-C) MODULATORS

  2005influential reference
• Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry.

  2005cited by this paper

• Mechanisms of intestinal pharmacokinetic natural product-drug interactions

  2024cites this paper
• Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms.

  2024cites this paper
• A comprehensive review on pharmacokinetic mechanism of herb-herb/drug interactions in Chinese herbal formula.

  2024cites this paper
• Circulating low-molecular-weight (poly)phenol metabolites in the brain: unveiling in vitro and in vivo blood–brain barrier transport

  2024cites this paper
• Herb-drug interactions: Quantitative analysis of levofloxacin absorption and transporter expression in the rat intestine following combined treatment with Persicaria capitata (Buch.-Ham. ex D. Don) H. Gross.

  2024cites this paper
• Clinically Relevant Herb–Drug Interactions: A 30-Year Historical Assessment

  2024cites this paper
• Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance

  2023cites this paper
• Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines

  2022cites this paper
• Cyanidin 3-glucoside targets a hepatic bilirubin transporter in rats.

  2022cites this paper
• Structure–Activity Relationship Analysis of Flavonoids and Its Inhibitory Activity Against BACE1 Enzyme Toward a Better Therapy for Alzheimer’s Disease

  2022cites this paper
• Pharmacokinetic characterization of drugs and new product development

  2021cites this paper
• Effect of Vernonia Amygdalina Leaf on Cytochrome P450 2D6- and 3A4-Mediated Metabolism of Dextromethorphan in Healthy Nigerian Subjects

  2021cites this paper
• Cyanidin 3-glucoside Is a Selective Inhibitor of Hepatic Bilirubin Uptake

  2021cites this paper
• The Chemical Lives of Young Filipinos

  2021cites this paper
• Hesperetin nanoparticles attenuate anxiogenic-like behavior and cerebral oxidative stress through the upregulation of antioxidant enzyme expression in experimental dementia of Alzheimer’s type

  2020cites this paper
• Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions

  2020cites this paper
• Low Molecular Weight (poly)Phenol Metabolites Across the Blood-Brain Barrier: The Underexplored Journey

  2020cites this paper
• The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions

  2020cites this paper
• Interpretation of Drug Interaction Using Systemic and Local Tissue Exposure Changes

  2020cites this paper
• The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.

  2019cites this paper
• Stimulatory effect on the transport mediated by organic anion transporting polypeptide 2B1

  2019cites this paper
• Lipid Accumulation and Chronic Kidney Disease

  2019cites this paper
• Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions

  2018cites this paper
• Effects of Natural Polyphenols on the Expression of Drug Efflux Transporter P-Glycoprotein in Human Intestinal Cells

  2018cites this paper
• Drug-plant interactions: Herbs and beyond

  2017cites this paper
• Prenatal developmental toxicity evaluation of IDM 01 , a botanical composition of 4 ‐ hydroxyisoleucine and trigonelline based standardized fenugreek seed extract , during organogenesis period of pregnancy in rats

  2017cites this paper
• Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements

  2017cites this paper
• Challenges and Opportunities in Protease-Activated Receptor Drug Development.

  2017cites this paper
• ROLE OF MDR3 IN DRUG-INDUCED CHOLESTATIC LIVER INJURY

  2016cites this paper
• ROLE OF MDR3 IN DRUG-INDUCED CHOLESTATIC LIVER INJURY

  2016cites this paper
• 1 Circulating (poly)phenol metabolites in the brain: unveiling in vitro and in vivo blood-brain barrier transport

  year unknowncites this paper